comparemela.com

Page 6 - Rhythm Pharmaceuticals Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analyst Expectations For Rhythm Pharmaceuticals s Future - Rhythm Pharmaceuticals (NASDAQ:RYTM)

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $52 00 at Wells Fargo & Company

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by Wells Fargo & Company from $53.00 to $52.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts have also recently weighed in on the stock. Needham & Company […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.